Universal Health Services, Inc.(UHS)Earnings, Financials & Key RatiosUniversal Health Services, Inc. (UHS) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the forward P/E of 6.21 suggests an attractive valuation, the inconsistent cash conversion and persistent labor cost headwinds warrant a cautious approach until operating leverage improves beyond the current 11.2% margin.
Universal Health Services, Inc. (UHS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Universal Health Services, Inc. (UHS) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 27, 2026 | $5.62vs $5.41+3.9% | $4.5Bvs $4.4B+2.5% |
| Q1 2026 | Feb 25, 2026 | $5.88vs $5.92-0.7% | $4.5Bvs $4.5B-0.4% |
| Q4 2025 | Oct 27, 2025 | $5.69vs $4.66+22.1% | $4.5Bvs $4.5B-0.2% |
| Q3 2025 | Jul 28, 2025 | $5.35vs $4.92+8.7% | $4.3Bvs $4.2B+1.1% |
Recent stock market news and headlines for Universal Health Services, Inc. (UHS)
KING OF PRUSSIA, Pa., July 6, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its second quarter ended June 30, 2026, after the market closes on Monday, July 27, 2026.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Medical-Hospital industry is adapting as care shifts beyond inpatient settings, demand rises and earnings outlook improves. THC, UHS, ACHC and CYH stand out.
Key metrics vs top competitors for Universal Health Services, Inc. (UHS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $161.26 | $10.09B | 6.98 | 9.71% | 8.57% | 21.01% | 0.49% | |
| $423.11 | $93.86B | 14.91 | 7.08% | 8.89% | — | — | |
| $191.20 | $16.75B | 12.34 | 3.12% | 7.94% | 19.56% | — | |
| $3.82 | $538.36M | 1.01 | -1.18% | -0.41% | — | — | |
| $170.87 | $9.98B | 29.26 | 18.72% | 6.89% | 16.61% | — | |
| $31.92 | $2.94B | -2.63 | 5.04% | -32.84% | -40.92% | — |
Universal Health Services, Inc. (UHS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Universal Health Services, Inc. (UHS) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 28, 2026·SEC
Apr 24, 2026·SEC
Mar 30, 2026·SEC
Get notified when UHS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Universal Health Services, Inc. (UHS) stock FAQ — growth, dividends, profitability & financials explained
Universal Health Services, Inc. (UHS) reported $17.76B in revenue for fiscal year 2025. This represents a 1392% increase from $1.19B in 1996.
Universal Health Services, Inc. (UHS) grew revenue by 9.7% over the past year. This is steady growth.
Yes, Universal Health Services, Inc. (UHS) is profitable, generating $1.52B in net income for fiscal year 2025 (8.6% net margin).
Yes, Universal Health Services, Inc. (UHS) pays a dividend with a yield of 0.49%. This makes it attractive for income-focused investors.
Universal Health Services, Inc. (UHS) has a return on equity (ROE) of 21.0%. This is excellent, indicating efficient use of shareholder capital.
Universal Health Services, Inc. (UHS) generated $894.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
